Share Price and Basic Stock Data
Last Updated: December 24, 2025, 8:16 pm
| PEG Ratio | 3.43 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fine Organic Industries Ltd operates in the organic chemicals sector and has shown robust revenue growth over the years. For the fiscal year ending March 2023, sales stood at ₹3,023 Cr, a substantial increase from ₹1,876 Cr in the previous fiscal year. However, the revenue trend has shown some fluctuations, with reported sales declining to ₹2,123 Cr in March 2024 before recovering to ₹2,269 Cr in March 2025. This indicates a volatile business environment, influenced by demand dynamics and operational challenges. Quarterly sales figures also reflect this volatility, with a peak of ₹919 Cr in September 2022, followed by a decline to ₹547 Cr in June 2023. The trailing twelve months (TTM) sales as of March 2025 stood at ₹2,309 Cr, indicating a moderate recovery. The market capitalization of ₹12,848 Cr and a P/E ratio of 32.1 suggest that investors maintain a positive outlook on the company’s potential despite recent revenue fluctuations.
Profitability and Efficiency Metrics
Fine Organic Industries has demonstrated commendable profitability metrics, with a reported net profit of ₹405 Cr for the most recent fiscal year. The company’s operating profit margin (OPM) stood at 21%, reflecting its ability to manage costs effectively amid fluctuating sales. The OPM has varied over the quarters, peaking at 34% in March 2023 before settling at 20% in December 2024. The return on equity (ROE) of 19.5% and return on capital employed (ROCE) of 26.4% further indicate the company’s efficiency in generating returns from shareholders’ equity and capital employed. Notably, the interest coverage ratio (ICR) is exceptionally high at 278.05x, signifying that the company comfortably meets its interest obligations. However, the cash conversion cycle (CCC) has lengthened to 110 days, highlighting potential inefficiencies in managing working capital, which could impact liquidity in the near term.
Balance Sheet Strength and Financial Ratios
The balance sheet of Fine Organic Industries reflects a strong financial position, with total assets reported at ₹2,511 Cr as of March 2025. The company has minimal borrowings, standing at just ₹16 Cr, which indicates a low debt burden and a conservative capital structure. Reserves have significantly increased to ₹2,462 Cr, providing a cushion for future investments and financial stability. The current ratio is robust at 8.46, signaling excellent short-term liquidity, while the quick ratio of 6.76 further confirms this strength. The price-to-book value (P/BV) ratio of 5.34x indicates that the stock is trading at a premium compared to its book value, suggesting investor confidence in the company’s future growth prospects. However, the decline in the asset turnover ratio to 0.98 indicates a potential inefficiency in utilizing assets to generate revenue compared to previous years.
Shareholding Pattern and Investor Confidence
Fine Organic Industries has a stable shareholding pattern, with promoters holding a significant 75% stake. This stability is complemented by institutional investors, including foreign institutional investors (FIIs) at 4.57% and domestic institutional investors (DIIs) at 12.02%. The public shareholding stands at 8.41%, reflecting a diverse investor base. Over recent quarters, FII holdings have fluctuated, declining from 5.91% in December 2022 to 4.57% in September 2025, suggesting a cautious approach from foreign investors. In contrast, DII participation has remained relatively stable, indicating sustained confidence from domestic institutions. The total number of shareholders has decreased to 97,992 as of September 2025, which may reflect consolidation in investor interest or market conditions. This pattern of shareholding indicates a resilient confidence in the company’s long-term prospects, underscored by the significant promoter stake.
Outlook, Risks, and Final Insight
Looking ahead, Fine Organic Industries faces both opportunities and challenges. The company’s strong liquidity position and low debt levels provide a solid foundation for future growth; however, potential risks include market volatility and the impact of fluctuating raw material prices, which could affect profitability margins. The recent decline in sales and fluctuating quarterly performance may pose concerns regarding demand stability in its core markets. Furthermore, the extended cash conversion cycle signals inefficiencies that need addressing to enhance working capital management. Fine Organic Industries must navigate these risks while leveraging its strong financial metrics to capitalize on growth opportunities. The outlook remains cautiously optimistic, hinging on the company’s ability to streamline operations and adapt to market conditions effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 102 Cr. | 285 | 456/243 | 236 | 392 | 0.04 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,732 Cr. | 9,753 | 14,250/8,150 | 56.0 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 35.0 Cr. | 117 | 329/109 | 17.3 | 26.9 | 0.86 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 313 Cr. | 391 | 435/163 | 17.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,289.77 Cr | 1,550.09 | 65.25 | 334.84 | 0.41% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 748 | 919 | 760 | 597 | 547 | 540 | 488 | 547 | 550 | 596 | 517 | 607 | 588 |
| Expenses | 533 | 665 | 600 | 395 | 407 | 410 | 371 | 403 | 410 | 446 | 414 | 487 | 466 |
| Operating Profit | 214 | 254 | 159 | 202 | 140 | 130 | 117 | 144 | 139 | 150 | 103 | 120 | 123 |
| OPM % | 29% | 28% | 21% | 34% | 26% | 24% | 24% | 26% | 25% | 25% | 20% | 20% | 21% |
| Other Income | 17 | 19 | 15 | 13 | 14 | 17 | 17 | 22 | 24 | 22 | 25 | 26 | 47 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
| Depreciation | 11 | 12 | 12 | 13 | 12 | 14 | 15 | 15 | 12 | 12 | 13 | 15 | 12 |
| Profit before tax | 219 | 260 | 161 | 201 | 143 | 132 | 119 | 150 | 151 | 159 | 115 | 130 | 157 |
| Tax % | 27% | 22% | 34% | 26% | 30% | 22% | 21% | 24% | 25% | 26% | 28% | 25% | 26% |
| Net Profit | 160 | 203 | 106 | 149 | 100 | 103 | 94 | 115 | 113 | 117 | 83 | 97 | 117 |
| EPS in Rs | 52.12 | 66.09 | 34.65 | 48.74 | 32.54 | 33.71 | 30.73 | 37.36 | 36.94 | 38.30 | 26.97 | 31.68 | 38.19 |
Last Updated: August 20, 2025, 2:40 pm
Below is a detailed analysis of the quarterly data for Fine Organic Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 588.00 Cr.. The value appears to be declining and may need further review. It has decreased from 607.00 Cr. (Mar 2025) to 588.00 Cr., marking a decrease of 19.00 Cr..
- For Expenses, as of Jun 2025, the value is 466.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 487.00 Cr. (Mar 2025) to 466.00 Cr., marking a decrease of 21.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 123.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is 21.00%. The value appears strong and on an upward trend. It has increased from 20.00% (Mar 2025) to 21.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 21.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 157.00 Cr.. The value appears strong and on an upward trend. It has increased from 130.00 Cr. (Mar 2025) to 157.00 Cr., marking an increase of 27.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 117.00 Cr.. The value appears strong and on an upward trend. It has increased from 97.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 20.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 38.19. The value appears strong and on an upward trend. It has increased from 31.68 (Mar 2025) to 38.19, marking an increase of 6.51.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:45 am
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 660 | 778 | 856 | 1,060 | 1,038 | 1,133 | 1,876 | 3,023 | 2,123 | 2,269 | 2,309 |
| Expenses | 514 | 633 | 697 | 827 | 803 | 935 | 1,513 | 2,194 | 1,591 | 1,757 | 1,830 |
| Operating Profit | 146 | 145 | 158 | 234 | 235 | 198 | 363 | 829 | 532 | 512 | 479 |
| OPM % | 22% | 19% | 19% | 22% | 23% | 17% | 19% | 27% | 25% | 23% | 21% |
| Other Income | 8 | 4 | 16 | 20 | 20 | 17 | 33 | 64 | 71 | 98 | 119 |
| Interest | 7 | 4 | 3 | 2 | 5 | 6 | 5 | 5 | 2 | 2 | 2 |
| Depreciation | 30 | 24 | 20 | 17 | 35 | 47 | 40 | 48 | 57 | 52 | 53 |
| Profit before tax | 117 | 121 | 151 | 234 | 216 | 162 | 352 | 841 | 544 | 555 | 544 |
| Tax % | 35% | 36% | 37% | 40% | 24% | 26% | 26% | 26% | 24% | 26% | |
| Net Profit | 76 | 78 | 95 | 136 | 165 | 120 | 260 | 618 | 412 | 410 | 405 |
| EPS in Rs | 157.74 | 161.22 | 31.09 | 44.43 | 53.74 | 39.24 | 84.67 | 201.60 | 134.34 | 133.89 | 132.24 |
| Dividend Payout % | 29% | 9% | 23% | 16% | 13% | 28% | 11% | 4% | 7% | 8% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 2.63% | 21.79% | 43.16% | 21.32% | -27.27% | 116.67% | 137.69% | -33.33% | -0.49% |
| Change in YoY Net Profit Growth (%) | 0.00% | 19.16% | 21.36% | -21.83% | -48.60% | 143.94% | 21.03% | -171.03% | 32.85% |
Fine Organic Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 7% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 17% |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | -7% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 28% |
| Last Year: | 19% |
Last Updated: September 4, 2025, 9:35 pm
Balance Sheet
Last Updated: December 4, 2025, 12:51 am
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 249 | 323 | 380 | 485 | 604 | 716 | 944 | 1,526 | 1,906 | 2,280 | 2,462 |
| Borrowings | 102 | 40 | 54 | 128 | 125 | 89 | 59 | 29 | 4 | 3 | 16 |
| Other Liabilities | 63 | 76 | 81 | 74 | 108 | 127 | 219 | 237 | 182 | 213 | 167 |
| Total Liabilities | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,511 | 2,660 |
| Fixed Assets | 125 | 97 | 88 | 78 | 217 | 196 | 229 | 214 | 268 | 363 | 373 |
| CWIP | 6 | 3 | 32 | 106 | 6 | 26 | 14 | 40 | 30 | 27 | 36 |
| Investments | 0 | 11 | 11 | 10 | 33 | 31 | 31 | 39 | 36 | 35 | 34 |
| Other Assets | 289 | 334 | 399 | 508 | 597 | 694 | 962 | 1,513 | 1,774 | 2,085 | 2,218 |
| Total Assets | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,511 | 2,660 |
Below is a detailed analysis of the balance sheet data for Fine Organic Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,462.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,280.00 Cr. (Mar 2025) to 2,462.00 Cr., marking an increase of 182.00 Cr..
- For Borrowings, as of Sep 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 167.00 Cr.. The value appears to be improving (decreasing). It has decreased from 213.00 Cr. (Mar 2025) to 167.00 Cr., marking a decrease of 46.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,660.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,511.00 Cr. (Mar 2025) to 2,660.00 Cr., marking an increase of 149.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 373.00 Cr.. The value appears strong and on an upward trend. It has increased from 363.00 Cr. (Mar 2025) to 373.00 Cr., marking an increase of 10.00 Cr..
- For CWIP, as of Sep 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,218.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,085.00 Cr. (Mar 2025) to 2,218.00 Cr., marking an increase of 133.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,660.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,511.00 Cr. (Mar 2025) to 2,660.00 Cr., marking an increase of 149.00 Cr..
Notably, the Reserves (2,462.00 Cr.) exceed the Borrowings (16.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 44.00 | 105.00 | 104.00 | 106.00 | 110.00 | 109.00 | 304.00 | 800.00 | 528.00 | 509.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 49 | 52 | 62 | 54 | 47 | 52 | 59 | 42 | 54 | 53 |
| Inventory Days | 72 | 68 | 58 | 50 | 79 | 63 | 72 | 91 | 78 | 100 |
| Days Payable | 50 | 47 | 46 | 30 | 51 | 49 | 47 | 36 | 41 | 43 |
| Cash Conversion Cycle | 71 | 72 | 75 | 74 | 74 | 66 | 84 | 97 | 91 | 110 |
| Working Capital Days | 80 | 69 | 80 | 76 | 63 | 65 | 79 | 76 | 77 | 104 |
| ROCE % | 35% | 38% | 44% | 32% | 22% | 39% | 65% | 31% | 26% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 785,023 | 0.51 | 346.87 | 752,764 | 2025-12-08 07:42:13 | 4.29% |
| SBI Small Cap Fund | 666,183 | 0.81 | 294.36 | 700,000 | 2025-12-06 00:21:08 | -4.83% |
| Axis Small Cap Fund | 633,550 | 1.05 | 279.94 | 713,350 | 2025-12-06 00:21:08 | -11.19% |
| Axis Midcap Fund | 307,724 | 0.42 | 135.97 | 307,724 | 2025-04-22 15:57:01 | 0% |
| Axis Flexi Cap Fund | 303,189 | 1.01 | 133.97 | 304,168 | 2025-12-07 10:03:29 | -0.32% |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 170,399 | 1.17 | 75.29 | N/A | N/A | N/A |
| UTI Small Cap Fund | 93,777 | 0.86 | 41.44 | 46,684 | 2025-12-08 01:35:25 | 100.88% |
| ICICI Prudential Multicap Fund | 56,818 | 0.16 | 25.11 | N/A | N/A | N/A |
| WhiteOak Capital Flexi Cap Fund | 38,114 | 0.25 | 16.84 | N/A | N/A | N/A |
| Canara Robeco Small Cap Fund | 32,174 | 0.11 | 14.22 | 50,799 | 2025-12-15 04:31:28 | -36.66% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 133.89 | 134.34 | 201.60 | 84.71 | 39.25 |
| Diluted EPS (Rs.) | 133.89 | 134.34 | 201.60 | 84.71 | 39.25 |
| Cash EPS (Rs.) | 151.21 | 153.52 | 217.80 | 98.06 | 54.93 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 748.61 | 626.57 | 502.69 | 312.85 | 238.57 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 748.61 | 626.57 | 502.69 | 312.85 | 238.57 |
| Revenue From Operations / Share (Rs.) | 740.10 | 692.42 | 986.00 | 611.96 | 369.61 |
| PBDIT / Share (Rs.) | 199.11 | 197.62 | 291.99 | 129.67 | 70.56 |
| PBIT / Share (Rs.) | 182.06 | 179.31 | 276.37 | 116.66 | 55.31 |
| PBT / Share (Rs.) | 181.34 | 178.33 | 274.88 | 114.99 | 53.31 |
| Net Profit / Share (Rs.) | 134.16 | 135.20 | 202.18 | 85.04 | 39.68 |
| NP After MI And SOA / Share (Rs.) | 133.89 | 134.34 | 201.60 | 84.67 | 39.24 |
| PBDIT Margin (%) | 26.90 | 28.54 | 29.61 | 21.18 | 19.09 |
| PBIT Margin (%) | 24.59 | 25.89 | 28.02 | 19.06 | 14.96 |
| PBT Margin (%) | 24.50 | 25.75 | 27.87 | 18.79 | 14.42 |
| Net Profit Margin (%) | 18.12 | 19.52 | 20.50 | 13.89 | 10.73 |
| NP After MI And SOA Margin (%) | 18.09 | 19.40 | 20.44 | 13.83 | 10.61 |
| Return on Networth / Equity (%) | 17.88 | 21.44 | 40.10 | 27.06 | 16.45 |
| Return on Capital Employeed (%) | 24.30 | 28.58 | 54.94 | 36.30 | 21.39 |
| Return On Assets (%) | 16.35 | 19.54 | 34.21 | 20.99 | 12.70 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.06 | 0.07 |
| Asset Turnover Ratio (%) | 0.98 | 1.08 | 2.01 | 1.71 | 1.24 |
| Current Ratio (X) | 8.46 | 9.13 | 5.37 | 3.53 | 4.01 |
| Quick Ratio (X) | 6.76 | 7.71 | 3.68 | 2.60 | 3.20 |
| Inventory Turnover Ratio (X) | 7.28 | 3.07 | 7.20 | 7.44 | 5.95 |
| Dividend Payout Ratio (NP) (%) | 7.46 | 6.69 | 4.46 | 12.99 | 7.64 |
| Dividend Payout Ratio (CP) (%) | 6.62 | 5.89 | 4.14 | 11.26 | 5.50 |
| Earning Retention Ratio (%) | 92.54 | 93.31 | 95.54 | 87.01 | 92.36 |
| Cash Earning Retention Ratio (%) | 93.38 | 94.11 | 95.86 | 88.74 | 94.50 |
| Interest Coverage Ratio (X) | 278.05 | 249.04 | 195.73 | 77.82 | 35.30 |
| Interest Coverage Ratio (Post Tax) (X) | 188.34 | 171.61 | 136.52 | 52.03 | 20.84 |
| Enterprise Value (Cr.) | 11296.88 | 11309.92 | 12708.88 | 12135.04 | 6792.44 |
| EV / Net Operating Revenue (X) | 4.98 | 5.33 | 4.20 | 6.47 | 5.99 |
| EV / EBITDA (X) | 18.50 | 18.67 | 14.20 | 30.52 | 31.40 |
| MarketCap / Net Operating Revenue (X) | 5.40 | 5.82 | 4.37 | 6.56 | 6.18 |
| Retention Ratios (%) | 92.53 | 93.30 | 95.53 | 87.00 | 92.35 |
| Price / BV (X) | 5.34 | 6.43 | 8.57 | 12.83 | 9.57 |
| Price / Net Operating Revenue (X) | 5.40 | 5.82 | 4.37 | 6.56 | 6.18 |
| EarningsYield | 0.03 | 0.03 | 0.04 | 0.02 | 0.01 |
After reviewing the key financial ratios for Fine Organic Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
- For Cash EPS (Rs.), as of Mar 25, the value is 151.21. This value is within the healthy range. It has decreased from 153.52 (Mar 24) to 151.21, marking a decrease of 2.31.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 748.61. It has increased from 626.57 (Mar 24) to 748.61, marking an increase of 122.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 748.61. It has increased from 626.57 (Mar 24) to 748.61, marking an increase of 122.04.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 740.10. It has increased from 692.42 (Mar 24) to 740.10, marking an increase of 47.68.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 199.11. This value is within the healthy range. It has increased from 197.62 (Mar 24) to 199.11, marking an increase of 1.49.
- For PBIT / Share (Rs.), as of Mar 25, the value is 182.06. This value is within the healthy range. It has increased from 179.31 (Mar 24) to 182.06, marking an increase of 2.75.
- For PBT / Share (Rs.), as of Mar 25, the value is 181.34. This value is within the healthy range. It has increased from 178.33 (Mar 24) to 181.34, marking an increase of 3.01.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 134.16. This value is within the healthy range. It has decreased from 135.20 (Mar 24) to 134.16, marking a decrease of 1.04.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 133.89. This value is within the healthy range. It has decreased from 134.34 (Mar 24) to 133.89, marking a decrease of 0.45.
- For PBDIT Margin (%), as of Mar 25, the value is 26.90. This value is within the healthy range. It has decreased from 28.54 (Mar 24) to 26.90, marking a decrease of 1.64.
- For PBIT Margin (%), as of Mar 25, the value is 24.59. This value exceeds the healthy maximum of 20. It has decreased from 25.89 (Mar 24) to 24.59, marking a decrease of 1.30.
- For PBT Margin (%), as of Mar 25, the value is 24.50. This value is within the healthy range. It has decreased from 25.75 (Mar 24) to 24.50, marking a decrease of 1.25.
- For Net Profit Margin (%), as of Mar 25, the value is 18.12. This value exceeds the healthy maximum of 10. It has decreased from 19.52 (Mar 24) to 18.12, marking a decrease of 1.40.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.09. This value is within the healthy range. It has decreased from 19.40 (Mar 24) to 18.09, marking a decrease of 1.31.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.88. This value is within the healthy range. It has decreased from 21.44 (Mar 24) to 17.88, marking a decrease of 3.56.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.30. This value is within the healthy range. It has decreased from 28.58 (Mar 24) to 24.30, marking a decrease of 4.28.
- For Return On Assets (%), as of Mar 25, the value is 16.35. This value is within the healthy range. It has decreased from 19.54 (Mar 24) to 16.35, marking a decrease of 3.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.08 (Mar 24) to 0.98, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 8.46. This value exceeds the healthy maximum of 3. It has decreased from 9.13 (Mar 24) to 8.46, marking a decrease of 0.67.
- For Quick Ratio (X), as of Mar 25, the value is 6.76. This value exceeds the healthy maximum of 2. It has decreased from 7.71 (Mar 24) to 6.76, marking a decrease of 0.95.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.28. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 7.28, marking an increase of 4.21.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.46. This value is below the healthy minimum of 20. It has increased from 6.69 (Mar 24) to 7.46, marking an increase of 0.77.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.62. This value is below the healthy minimum of 20. It has increased from 5.89 (Mar 24) to 6.62, marking an increase of 0.73.
- For Earning Retention Ratio (%), as of Mar 25, the value is 92.54. This value exceeds the healthy maximum of 70. It has decreased from 93.31 (Mar 24) to 92.54, marking a decrease of 0.77.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.38. This value exceeds the healthy maximum of 70. It has decreased from 94.11 (Mar 24) to 93.38, marking a decrease of 0.73.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 278.05. This value is within the healthy range. It has increased from 249.04 (Mar 24) to 278.05, marking an increase of 29.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 188.34. This value is within the healthy range. It has increased from 171.61 (Mar 24) to 188.34, marking an increase of 16.73.
- For Enterprise Value (Cr.), as of Mar 25, the value is 11,296.88. It has decreased from 11,309.92 (Mar 24) to 11,296.88, marking a decrease of 13.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.98. This value exceeds the healthy maximum of 3. It has decreased from 5.33 (Mar 24) to 4.98, marking a decrease of 0.35.
- For EV / EBITDA (X), as of Mar 25, the value is 18.50. This value exceeds the healthy maximum of 15. It has decreased from 18.67 (Mar 24) to 18.50, marking a decrease of 0.17.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.40. This value exceeds the healthy maximum of 3. It has decreased from 5.82 (Mar 24) to 5.40, marking a decrease of 0.42.
- For Retention Ratios (%), as of Mar 25, the value is 92.53. This value exceeds the healthy maximum of 70. It has decreased from 93.30 (Mar 24) to 92.53, marking a decrease of 0.77.
- For Price / BV (X), as of Mar 25, the value is 5.34. This value exceeds the healthy maximum of 3. It has decreased from 6.43 (Mar 24) to 5.34, marking a decrease of 1.09.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.40. This value exceeds the healthy maximum of 3. It has decreased from 5.82 (Mar 24) to 5.40, marking a decrease of 0.42.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fine Organic Industries Ltd:
- Net Profit Margin: 18.12%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.3% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.88% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 188.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 32 (Industry average Stock P/E: 65.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.12%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Fine House, Anandji Street, Mumbai Maharashtra 400077 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mukesh Shah | Chairman & Wholetime Director |
| Mr. Jayen Shah | Managing Director |
| Mr. Tushar Shah | WholeTime Director & CEO |
| Mr. Bimal Shah | Executive Director |
| Mr. Nikhil Kamat | Executive Director |
| Mr. Kaushik Shah | Independent Director |
| Mr. Mahesh Sarda | Independent Director |
| Mr. Thiruvengadam Parthasarathi | Independent Director |
| Ms. Pratima Umarji | Independent Director |
| Mr. Prakash Apte | Independent Director |
| Ms. Rashi Mehta | Independent Director |
FAQ
What is the intrinsic value of Fine Organic Industries Ltd?
Fine Organic Industries Ltd's intrinsic value (as of 24 December 2025) is 4044.02 which is 3.32% lower the current market price of 4,183.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 12,824 Cr. market cap, FY2025-2026 high/low of 5,494/3,355, reserves of ₹2,462 Cr, and liabilities of 2,660 Cr.
What is the Market Cap of Fine Organic Industries Ltd?
The Market Cap of Fine Organic Industries Ltd is 12,824 Cr..
What is the current Stock Price of Fine Organic Industries Ltd as on 24 December 2025?
The current stock price of Fine Organic Industries Ltd as on 24 December 2025 is 4,183.
What is the High / Low of Fine Organic Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fine Organic Industries Ltd stocks is 5,494/3,355.
What is the Stock P/E of Fine Organic Industries Ltd?
The Stock P/E of Fine Organic Industries Ltd is 32.0.
What is the Book Value of Fine Organic Industries Ltd?
The Book Value of Fine Organic Industries Ltd is 808.
What is the Dividend Yield of Fine Organic Industries Ltd?
The Dividend Yield of Fine Organic Industries Ltd is 0.26 %.
What is the ROCE of Fine Organic Industries Ltd?
The ROCE of Fine Organic Industries Ltd is 26.4 %.
What is the ROE of Fine Organic Industries Ltd?
The ROE of Fine Organic Industries Ltd is 19.5 %.
What is the Face Value of Fine Organic Industries Ltd?
The Face Value of Fine Organic Industries Ltd is 5.00.